← Back to Discover
Foresite Capital Management V, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $362,202,120
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ALUMIS INC. · COM · 022307102 · shares: $165,941,439
- CG Oncology, Inc. · COM · 156944100 · shares: $76,666,503
- Disc Medicine, Inc. · COM · 254604101 · shares: $27,359,407
- Hims & Hers Health, Inc. · COM CL A · 433000106 · shares: $25,591,695
- Pharvaris N.V. · COM · N69605108 · shares: $22,966,030
- Eikon Therapeutics, Inc. · COM · 282564103 · shares: $17,212,728
- Odyssey Therapeutics, Inc. · COM · 67613T104 · shares: $13,342,195
- Lyell Immunopharma, Inc. · COM · 55083R203 · shares: $6,693,223
- Nurix Therapeutics, Inc. · COM · 67080M103 · shares: $6,428,900
Reported holdings
9 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ALUMIS INC. | COM | 022307102 | — | 5,896,995 shares | $165,941,439 |
| CG Oncology, Inc. | COM | 156944100 | — | 1,079,050 shares | $76,666,503 |
| Disc Medicine, Inc. | COM | 254604101 | — | 374,069 shares | $27,359,407 |
| Hims & Hers Health, Inc. | COM CL A | 433000106 | — | 738,151 shares | $25,591,695 |
| Pharvaris N.V. | COM | N69605108 | — | 664,142 shares | $22,966,030 |
| Eikon Therapeutics, Inc. | COM | 282564103 | — | 1,318,983 shares | $17,212,728 |
| Odyssey Therapeutics, Inc. | COM | 67613T104 | — | 713,105 shares | $13,342,195 |
| Lyell Immunopharma, Inc. | COM | 55083R203 | — | 476,386 shares | $6,693,223 |
| Nurix Therapeutics, Inc. | COM | 67080M103 | — | 265,000 shares | $6,428,900 |